Miren Taberna

3.9k citations
70 papers · 2.5k · 5 hit papers · h-index 23

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Cancer survivorship and care
    • Cancer Cells and Metastasis

Papers in

    • Head and Neck Cancer Studies 46
    • Cancer Immunotherapy and Biomarkers 5
    • Inflammatory Biomarkers in Disease Prognosis 2

Miren Taberna

65 papers receiving 2.5k citations

Miren Taberna's Hit Papers

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial 2024 · 141 citations
1410+3+6Years since publication100200300

Peers

Miren Taberna
Comparison fields: 5 of 111
  • Otorhinolaryngology 1.4k
  • Oncology 452
  • Periodontics 65
  • Health Informatics 23
  • Epidemiology 198
Replace Benjamin L. Judson with:
Benjamin L. Judson United States
Jose Pedro Zevallos United States
John D. Cramer United States
Bidhu Kalyan Mohanti India
Atul Sharma India
Marita S. Teng United States
Ali Sharifi Iran
Shih‐An Liu Taiwan
Stephanie Shintani Smith United States
Toru Hiyama Japan
Miren Taberna relative to Benjamin L. Judson United States Benjamin L. Judson's profile →
Citations per field
00.5×1.7×
Benjamin L. Judson · 1×
Citations per year

Countries citing papers authored by Miren Taberna

Since Specialization
Citations

This map shows the geographic impact of Miren Taberna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miren Taberna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miren Taberna more than expected).

Fields of papers citing papers by Miren Taberna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miren Taberna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miren Taberna. The network helps show where Miren Taberna may publish in the future.

Co-authors

The 25 scholars most cited alongside Miren Taberna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Miren Taberna Line = papers co-authored together Miren Taberna links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Human papillomavirus-related oropharyngeal cancer
Hit paper breakdown →
2017319
2
The Multidisciplinary Team (MDT) Approach and Quality of Care
Hit paper breakdown →
2020306
3 2018209
4
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis
Hit paper breakdown →
2023202
5
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
Hit paper breakdown →
2021157
6
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
Hit paper breakdown →
2024141
7 2022121
8 201991
9 201874
10 202172
11 201757
12 202154
13 201747
14 201637
15 201633
16 201532
17 202032
18 201631
19 201630
20 201829

About Miren Taberna

Miren Taberna is a scholar working on Otorhinolaryngology, Oncology, Physiology, Epidemiology and Periodontics, having authored 70 papers that have together received 2.5k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (46 papers), Cancer Immunotherapy and Biomarkers (5 papers), Nutrition and Health in Aging (5 papers), Lung Cancer Treatments and Mutations (2 papers), Cervical Cancer and HPV Research (2 papers), Oral Health Pathology and Treatment (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Spondyloarthritis Studies and Treatments (2 papers). The work is most often cited by research in Otorhinolaryngology (1.4k citations), Oncology (452 citations), Periodontics (65 citations), Health Informatics (23 citations) and Epidemiology (198 citations). Miren Taberna has collaborated with scholars based in Spain, Canada and United States. Frequent co-authors include Ricard Mesı́a, Marisa Mena, Laia Alemany, Maura L. Gillison, Marc Oliva Bernal, Miguel Ángel Pavón, Lorena Arribas, Esther Vilajosana, Francisco Gil and Enric Jané Salas. Their work appears in journals such as Annals of Oncology, Oral Oncology, Clinical & Translational Oncology, The Lancet Oncology and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact